The tick Amblyomma sculptum is the vector of the bacterium Rickettsia rickettsii (which causes Brazilian Spotted Fever in humans). It can be found in domestic and wild animals, as well as humans. The objective of this work was to evaluate the efficacy of baits containing fluazuron in the control of A. sculptum in guinea pigs that were artificially infested. The work was conducted in two studies: descriptive pharmacokinetics and efficacy. Descriptive pharmacokinetics was assessed after administering one fluazuron-containing bait per animal (10 mg/kg). To determine the pharmacokinetic profile, blood samples were collected over several days. For the efficacy test, the animals were divided into four groups: a control group (untreated) and three treated groups that received a single dose of 10 mg/kg on days −21 (G1), −14 (G2) and −7 (G3). All animals were infested with A. sculptum larvae on day 0 and recovered on days +4, +5, +6, and +7. Fluazuron plasma concentrations increased rapidly, indicating rapid absorption, and decreased slowly. In all treated groups, engorged larvae with morphological and behavioral changes were observed. Although fluazuron did not show acaricidal efficacy, it was able to interfere with tick molting. Fluazuron was effective in controlling the A. sculptum tick in guinea pigs.
The control of ectoparasites in dogs is challenged by resistance and the environmental impacts of synthetic pesticides, driving the search for plant-based alternatives. This study evaluated the clinical efficacy and safety of a spray formulation containing carvacrol (10%) and eugenol (10%) against experimental infestations by the tick Rhipicephalus linnaei and the flea Ctenocephalides felis felis in dogs. Sixteen Beagles were randomly allocated to a treated group (TG, n = 8) and an untreated control group (CG, n = 8). The animals were artificially infested on days -2, + 5, and + 12, and parasite counts were performed on days + 2, + 7, and + 14. Efficacy was calculated as the percent reduction of arithmetic means relative to the CG. Safety was assessed through daily clinical examinations and hematological and biochemical analyses. The formulation achieved high initial therapeutic efficacy, with reductions of 96% for R. linnaei and 98% for C. felis felis on day + 2, meeting reference efficacy thresholds for ectoparasiticides. On days + 7 and + 14, reductions were lower (49-56% for fleas and 11-49% for ticks) and, despite remaining statistically significant compared to controls, did not reach the levels required to claim residual efficacy. No local or systemic adverse events were observed, and laboratory parameters remained within reference ranges for the respective species, with no significant differences between groups (p > 0.05). The results demonstrate that the carvacrol and eugenol spray formulation is effective for the therapeutic control of tick and flea infestations in dogs, representing a promising plant-based alternative.